TJP1 and obesity disorder: ZO-1 levels in serum are inversely related to its intestinal expression and serum ZO-1 is an established marker of increased intestinal paracellular permeability in diverse pathological conditions such as in inflammatory bowel disease, celiac disease, diabetes type 1, obesity and rheumatoid arthritis [45,46,47].